CorMedix Inc. - Common Stock (NQ:CRMD)

5.320 +0.090 (+1.72%)

Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CorMedix Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

CLASS ACTION UPDATE for SRAC, OCGN and CRMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

August 01, 2021

NEW YORK, NY / ACCESSWIRE / August 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

From Levi & Korsinsky, LLP

Via AccessWire

Topics Lawsuit

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CorMedix Inc. (CRMD) Investors

July 31, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HMPT, COIN and CRMD

July 30, 2021

NEW YORK, NY / ACCESSWIRE / July 30, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

Topics Lawsuit

CRMD SHAREHOLDER ALERT: Investors with Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit

July 30, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of CorMedix Inc. (CRMD) Investors

July 30, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

CRMD Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces CorMedix Inc. Class Action and Encourages Investors to Contact the Firm

July 30, 2021

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against CorMedix Inc. (NASDAQ: CRMD) and September 20 Deadline

July 29, 2021

From Scott+Scott Attorneys at Law LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of CorMedix Inc. (CRMD) Investors

July 29, 2021

From Law Offices of Howard G. Smith

Via Business Wire

Lawsuits Filed Against HMPT, YMM and CRMD - Jakubowitz Law Pursues Shareholders Claims

July 29, 2021

NEW YORK, NY / ACCESSWIRE / July 29, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JRVR, BZ and CRMD

July 29, 2021

NEW YORK, NY / ACCESSWIRE / July 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Lawsuit

The Law Offices of Frank R. Cruz Announces Investigation of CorMedix Inc. (CRMD) on Behalf of Investors

July 28, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

SHAREHOLDER ALERT: Robbins LLP Announces that CorMedix Inc. (CRMD) is Being Sued for Misleading Shareholders

July 28, 2021

From Robbins LLP

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CorMedix Inc. (CRMD) on Behalf of Investors

July 28, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CorMedix Inc. (CRMD) on Behalf of Investors

July 28, 2021

From Law Offices of Howard G. Smith

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

July 27, 2021

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

July 26, 2021

From The Schall Law Firm

Via Business Wire

CRMD INVESTOR NOTICE: Rosen Law Firm Encourages CorMedix Inc. Investors with Losses to Secure Counsel Before Important Deadline – CRMD

July 26, 2021

From Rosen Law Firm

Via Business Wire

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CorMedix Inc. and Encourages Investors to Contact the Firm

July 23, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

CRMD ALERT: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit

July 23, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks ↗

May 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

High Flyers At Much Lower Altitudes ↗

May 14, 2021

Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd.

Via Talk Markets

74 Biggest Movers From Friday ↗

May 17, 2021

Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps 400 Points; CorMedix Shares Slide ↗

May 14, 2021

Toward the end of trading Friday, the Dow traded up 1.19% to 34,424.80 while the NASDAQ rose 2.41% to 13,440.75. The S&P also rose, gaining 1.62% to 4,179.15. The U.S. has the...

Via Benzinga

Topics Stocks

Dow Eyes Strong Close to Volatile Week With Triple-Digit Pop ↗

May 14, 2021

The Dow Jones Industrial Average is looking to finish a volatile week on a high note, up roughly 270 points this afternoon and building on yesterday's rally.

Via Talk Markets

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 14, 2021

Gainers Atea Pharmaceuticals (NASDAQ:AVIR) stock moved upwards by 24.11% to $23.86 during Friday's regular session. The current volume of 967.7K shares is 156.13% of...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 2%; CorMedix Shares Drop Following Q1 Results ↗

May 14, 2021

Midway through trading Friday, the Dow traded up 0.85% to 34,310.56 while the NASDAQ rose 1.88% to 13,371.18. The S&P also rose, gaining 1.26% to 4,164.50. The U.S. has the...

Via Benzinga

Topics Stocks

Why Bionano Genomics, CorMedix and Eloxx Are Moving Friday ↗

May 14, 2021

Bionano Genomics, Inc. (NASDAQ: BNGO), CorMedix Inc. (NASDAQ: CRMD) and Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) are among the health care movers Friday. Bionano Moves On Q1...

Via Benzinga

54 Stocks Moving In Friday's Mid-Day Session ↗

May 14, 2021

Gainers HyreCar Inc. (NASDAQ: HYRE) shares jumped 44.5% to $12.93 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares jumped 39.8% to $4.04. MoSys, last week...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Disney Sales Miss Expectations ↗

May 14, 2021

Following the market opening Friday, the Dow traded up 0.80% to 34,292.31 while the NASDAQ rose 1.50% to 13,321.23. The S&P also rose, gaining 1.06% to 4,156.04. The U.S. has...

Via Benzinga

Topics Earnings Stocks

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 14, 2021

Gainers Biolase (NASDAQ:BIOL) shares increased by 27.6% to $0.74 during Friday's pre-market session. The company's market cap stands at $111.4 million. As per the...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.